Business Combination between SPAC Oaktree Acquisition Corp. II and Alvotech

Posted - 10.12.2021

| Selected Deals

Now reading : Business Combination between SPAC Oaktree Acquisition Corp. II and Alvotech

Elvinger Hoss Prussen acted as Luxembourg legal counsel to Oaktree Acquisition Corp. II, a special purpose acquisition company sponsored by an affiliate of Oaktree Capital Management, L.P. on its entry into a definitive business combination agreement with Alvotech Holdings S.A., a leading global biopharmaceutical company focused on the development and manufacture of biosimilar medicines for patients worldwide.

Partner Karl Pardaens led the Elvinger Hoss Prussen team composed of Senior Associate Justine Peduzzi and Associates Lars Falkenberg and Ozan Imrek.